X0306 4 2021-03-15 0 0001434316 FATE THERAPEUTICS INC FATE 0001748177 Valamehr Bahram C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 Chief Development Officer Common Stock 2021-03-15 4 M 0 25000 2.90 D 120740 D Common Stock 2021-03-15 4 S 0 3957 90.8907 D 116783 D Common Stock 2021-03-15 4 S 0 8416 91.9418 D 108367 D Common Stock 2021-03-15 4 S 0 8404 92.6437 D 99963 D Common Stock 2021-03-15 4 S 0 3205 93.7475 D 96758 D Common Stock 2021-03-15 4 S 0 1018 94.5944 D 95740 D Stock Option (Right to Buy) 2.90 2021-03-15 4 M 0 25000 0.00 D 2026-01-07 Common Stock 25000 16156 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020. Represents the weighted average sale price of the shares sold from $90.30 to $91.29 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6. Represents the weighted average sale price of the shares sold from $91.30 to $92.29 per share. Represents the weighted average sale price of the shares sold from $92.31 to $93.27 per share. Represents the weighted average sale price of the shares sold from $93.31 to $94.29 per share. Represents the weighted average sale price of the shares sold from $94.40 to $94.90 per share. This option is fully vested. /s/ Cindy Tahl, Attorney-in-Fact 2021-03-16